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ABSTRACT
Fragile X syndrome (FXS), the most common form of
inherited intellectual disability, is caused by the si-
lencing of the FMR1 gene encoding an RNA-binding
protein (FMRP) mainly involved in translational con-
trol. We characterized the interaction between FMRP
and the mRNA of GRK4, a member of the gua-
nine nucleotide-binding protein (G protein)-coupled
receptor kinase super-family, both in vitro and in
vivo. While the mRNA level of GRK4 is unchanged
in the absence or in the presence of FMRP in dif-
ferent regions of the brain, GRK4 protein level is
increased in Fmr1-null cerebellum, suggesting that
FMRP negatively modulates the expression of GRK4
at the translational level in this brain region. The C-
terminal region of FMRP interacts with a domain of
GRK4 mRNA, that we called G4RIF, that is folded
in four stem loops. The SL1 stem loop of G4RIF is
protected by FMRP and is part of the S1/S2 sub-
domain that directs translation repression of a re-
porter mRNA by FMRP. These data confirm the role
of the G4RIF/FMRP complex in translational regu-
lation. Considering the role of GRK4 in GABAB re-
ceptors desensitization, our results suggest that an
increased GRK4 levels in FXS might contribute to
cerebellum-dependent phenotypes through a dereg-
ulated desensitization of GABAB receptors.
INTRODUCTION
Fragile X syndrome (FXS) is the first cause of inherited in-
tellectual disability (ID), affecting 1:4000 males and 1:7000
females and is characterized by moderate to severe ID, hy-
peractive behavior, autism, attention deficit, seizures and
sleep disorders (1). The cause of FXS is the silencing of
the FMR1 gene encoding FMRP, a protein localized in
various sub-cellular compartments (1). Indeed, FMRP is
endowed with several RNA-binding domains (1,2) and is
involved in different steps of RNA metabolism, namely
RNA export from nucleus to cytoplasm, translational regu-
lation and axonal/dendritic transport (1,3–4). To date,most
laboratories have focused their study on the function of
FMRP in translational control. Indeed, FMRP was shown
to bemainly associatedwith translating polyribosomes (80–
90%), suggesting that its main function is linked to transla-
tional regulation acting both as a repressor and as an en-
hancer of translation (4–8). A remarkable effort has been
made during the last years to define a large set of mRNAs
target of FMRP, but the vast majority of the candidates
awaits further molecular characterization and the func-
tional significance of these interactions need to be precisely
defined (4). The analyses of FMRP target mRNAs also re-
sulted in the identification of some motifs/structures medi-
ating their interaction with FMRP and validating the impli-
cation of the FMRP/RNA complex in translational regula-
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tion, but not in transport (4,9–10). Indeed, G-quadruplex,
kissing complex and ACUK/WGGA sequences have been
involved in translational repression mediated by FMRP.
Conversely, SoSLIP, a structure organized in three stem
loops separated by short sequences, is an activator of trans-
lation ‘per se’ and its activity is enhanced when bound by
FMRP (4). Interestingly, according to a recent in silico pre-
diction, several ACUK/WGGA sequences can be folded
in G-quadruplex forming structures when present in some
FMRP target mRNAs (11).
We characterized the interaction between FMRP and the
mRNA of GRK4, a member of the guanine nucleotide-
binding protein (G protein)-coupled receptor kinase super-
family, both in vitro and in vivo. FMRP negatively mod-
ulates the expression of GRK4 at the translational level
by binding an RNA structure that was never previously
described as target of FMRP. It has been shown that, in
cerebellar granule cells, GRK4 interacts directly with the
metabotropic GABAB receptor (GBR), promoting its de-
sensitization (12). Cerebellum GBRs signaling has a piv-
otal role in motor learning and coordination (13). With this
premise, the elevated level of GRK4 in Fmr1-null cerebel-
lum could determine an increased desensitization of GBRs
specifically in this brain region and contribute to deficits
of motor learning and movement coordination that are
cerebellum-dependent phenotypes of FXS (14).
MATERIALS AND METHODS
Reverse transcription (RT)-PCR and quantitative real-time
PCR
Total RNAs were extracted from mouse cerebellum and
hippocampus using the RNeasy kit (Qiagen) and retro-
transcribed by the SuperScript II first-strand synthesis sys-
tem (Invitrogen). We evaluated the relative GRK4 mRNA
expression in mouse cortex, hippocampus and cerebel-
lum in adult wild-type versus Fmr1 null mice by quan-
titative real-time polymerase chain reaction (PCR) by
this set of primers: F: CCTGATCCTCAGGCCATTTATT,
R: GGTATCCAGGTTGACTCCTTTCA. Real-time PCR
was performed using LightCycler 480 Real-Time PCR Sys-
tem (Roche) using the cDNA, qPCR Core kit for SYBR
Green (Eurogentec) according to the manufacturer’s in-
structions and as previously described (6). All experiments
were performed in triplicate. The relative expressions of
transcripts were quantified using 2−CT method. Mouse
TBP gene was used as a housekeeping gene for normaliza-
tion (15).
Western blot
Brain samples were thawed on ice, weighed and extracted in
2 ml/100 mg of cold extraction buffer (20 mM Tris pH 7.4,
2.5 mMMgCl2, 150 mMNaCl, 0.5% NP40) supplemented
with antiprotease cocktail (Roche). Lysates were homoge-
nized using a teflon potter fitted to 1.5 ml Eppendorf tubes
and centrifuged at 10 000 g for 10 min at 4◦C. Supernatant
was collected, and protein content was determined by spec-
trometry at 580 nmusing Bradford reagent (Biorad). A total
of 25 g of proteins were loaded on an 11% sodium dode-
cyl sulphate-polyacrylamide gel electrophoresis and west-
ern blotting was performed as previously described (16,17)
using rabbit polyclonal anti-GRK4 (Sigma-Aldrich).
Plasmids and constructs
Human GRK4 IMAGE clone 40125871 was used as a tem-
plate to subclone the five fragments ofGRK4 into pGEM-T
easy vector (Promega) by PCR amplification using the ap-
propriate primers whose sequences are reported in Table 1.
Fragments S1/S2, S2/S3, DegS1/S2 and DegS3/S4 were
generated using the primers listed in Table 2 and inserted in
the 5′ UTR (StuI site), the 3′ UTR (PmeI site) or in frame
in the middle of the coding sequence (EcorV site) of the Re-
nilla luciferase (no stop codons have been generated) in the
psiCHECK-2 vector (Promega). All constructs were veri-
fied by sequencing using a BigDye terminator sequencing
kit and an ABI 3130XL sequencer (Applied Biosystems).
Production and purification of recombinant proteins
Escherichia coli BL21 star (DE3) cells (Invitrogen) were
transformedwith histidine-tagged pET151/D-TopoFMRP
full-length, KH1, KH2 or RGG box constructs (6). The
cells were grown in LBmediumwith ampicillin (100mg/ml)
and induced for 4 h at 20◦C by addition of 1mM isopropyl-
-D-thiogalacto-pyranoside when the cultures reached an
OD of 0.4 at 600 nm. Cells were then harvested and resus-
pended in lysis buffer [25 mM Tris–HCl pH 7.6, 300 mM
KCl or LiCl, 1 mM EDTA, 1 mM dithiothreitol (DTT) ,
20% glycerol, 5% NP-40, 0.5M urea, complete protease in-
hibitor cocktail (Roche), 1 mM PMSF] sonicated for 5 min
and centrifuged at 15 000 r.p.m. for 30 min at 4◦C. The su-
pernatant was incubated with Ni-NTA Agarose beads (Qi-
agen) for 2 h at 4◦C by agitation. Beads were washed four
times at 4◦Cwith washing buffer (25 mMTris–HCl, pH 7.6,
300 mMKCl, 1 mMDTT, 0.5M urea, 20% glycerol, 20 mM
imidazole). Fusion proteins were eluted from the beads with
elution buffer (25 mMTris–HCl pH 7.6, 50 mMKCl, 1 mM
EDTA, 1 mMDTT, 10% glycerol, 0.1% Triton, 0.5M urea,
250 mM imidazole) for 30 min on ice.
RNA binding assays
RNA binding assay was performed as previously described
(6,18–19) using a filter binding assay using Multiscreen
Vacuum Manifold and the Multiscreen Separation System
(Millipore). A total of 2 pmol of recombinant FMRP were
used in each reaction.
CLIP (CrossLinking ImmunoPrecipitation)
Cerebellum fragments were sliced and dissociated in 6 ml
cold PBS buffer and UV irradiated for 100 mJ/cm2 in
Stratalinker on ice. Lysis of cerebellum fragments was per-
formed using the following lysis buffer: 50 mM Tris–HCl,
pH 7.4; 100 mM NaCl; 1 mM MgCl2; 0.1 mM CaCl2;
1% NP-40; 0.5% sodium deoxycholate; 0.1% SDS; pro-
tease inhibitor (Roche) and ANTI-RNase (Life Technolo-
gies) added fresh. Partial RNA digestion was performed
by adding 1 l of a dilution (1/10 000) of RNase I (Am-
bion). FMRP/RNA complexes were immunopreciptated
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Table 1. Primers used for cloning into pGEM-T easy
Fragments Primers
GRK4–5′ UTR F: CAGGGCACTGAGGAGGGAG
R: GTCCTGGCGCCGCCGCC
GRK4-Cod1 F:ATGGAGCTCGAGAACATCGTG
R: CAAACCTCTCCAAATCCGCC
GRK4-Cod2 F: GCGCCTGTCAAGTGCGAGC
R:CTTGATTCTTTGATCGACCTCC
GRK4-Cod2a F:GCGCCTGTCAAGTGCGAGC
R: GTATACAATTCTTTCCCTCTG
GRK4-Cod2a-a F:GCGCCTGTCAAGTGCGAGC
R:CAAGCACAAGGCATCTTTGG
GRK4-Cod2a-b F:CCAAAGATGCCTTGTGCTTG
R:GTATACAATTCTTTCCCTCTG
GRK4-Cod2b F:CAGAGGGAAAGAATTGTATAC
R:CTTGATTCTTTGATCGACCTCC
GRK4-Cod3 F:AATGATACCGAGGAGTATTCTG
R:GAAGTCTTCATCTGCGGTGTC
GRK4-Cod4 F:GACACCGCAGATGAAGACTTC
R: CAGGTGGGACGAGACGCTAA
Table 2. Primers used for cloning into psiCHECK-2 vector
Fragments Primers
S1/S2 F:TGCTTGGTGCTCACCATTATGAATGGAGGGGATTTGAAGTTTCACATTT
R:GGCTCTCTGCTCATCAAAGCCGGGATTGCCCAGGTTGTAAATGTGAAA
DegS1/S2 F:TGCCTGGTGCTGACCATTATGAACGGCGGCGATCTGAAATTTCATATTT
R:CGCGCGCTGTTCATCAAAGCCCGGGTTGCCCAGGTTATAAATATGAAAT
S3/S4 F:TTTGATGAGCAGAGAGCCGTTTTCTATGCTGCAGAGCTGTGTTGCGGC
R: GTATACAATTCTTTCCCTCTGTAAATCTTCCAAGCCGCAACACAGCTCT
DegS3/S4 F: TTTGATGAACAGCGCGCGGTGTTTTATGCGGCGGAACTGTGCTGCGGC
R:ATACACAATGCGTTCGCGCTGCAGATCTTCCAGGCCGCAGCACAGTTCC
overnight using protein A Dynabeads coupled to anti-
FMRP R60 antibody (20). Beads were then washed us-
ing a high salt washing buffer: 50 mM Tris–HCl, pH
7.4; 1 M NaCl; 1 mM EDTA; 1% NP-40; 0.5% sodium
deoxycholate; 0.1% SDS. FMRP was then degraded us-
ing 25 g proteinase K and the RNA was extracted by
phenol/chloroform. RNA fragments were precipitated then
reverse transcribed using random hexamers. cDNA was
used to perform real time PCR analysis using the primers
described in Table 3.
G-quadruplex-forming structure detection
The presence of a G-quadruplex structure in the GRK4
mRNA was tested both by reverse transcriptase-mediated
primer extension following a protocol adapted from (18).
Briefly, 100 ng of target RNA and 100 000 cpm of a 5′-
end labeled primer were heat denatured for 1 min at 90◦C,
then oligo was allowed to anneal to the template RNA for 5
min at 20◦C in HB-folding buffer (50 mM Hepes pH 7.0,
100 mM NaCl or KCl or LiCl, 167 nM EDTA). Primer
extensions were initiated by the addition of RT elongation
mix, containing 50 mM Tris ph8.5, 6 mM MgCl2, 40 mM
NaCl or KCl or LiCl, 1 mM dNTP and 3 unit of Super-
script II (Invitrogen). RT were performed at 37◦C for 30
min, then cDNA was precipitated with ethanol. After cen-
trifugation the pellet was resuspended in 6 l of RNA load-
ing buffer 2 (Ambion). cDNA was separated on 8% de-
naturing PAGE gel (National Diagnostic). Gels were then
fixed in a solution of 10%EtOH-6%Acetic acid in water, and
dried on an electrophoresis gel dryer (Biorad) and exposed
over night on BAS-MP Fujifilm imaging plate (Fujifilm)
or images were acquired with a FLA-5100 image reader
(Fujifilm). The presence of G-quadruplex-forming struc-
tures was detected by elongating  -32ATP 5′-end labeled
primers: R2 (5′ CTTGATTCTTTGATCGACCTCC’) for
the GRK4 mRNA, R2A (5′ GTATACAATTCTTTCC-
CTCTG3′) for theCod2mRNAandFMR1 FBS (5′ CTT-
TAGCCTCTCTTGGATTAC 3′) for the two control RNAs
N19 (positive control) and 35 (negative control).
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Table 3. Primers for qPCR for CLIP
GRK4 fragments Primers for qPCR
GRK4–5′ UTR F: TCCTCAAAGGACAAGGGATG
R: TTTCCGACGTCGAACTTTTC
GRK4-Cod1 F: GAACTTCGTGGCCAACAATC
R: CTGACTGGGGGAAACTTCAG
GRK4-Cod2 F: CAAGTACGAGCTACAGGAAAAATGT
R: CTATGCAATTTTTCTAAGATTCTTTTT
GRK4-Cod3 F: AAGTCCCAGAAGGGGAGATG
R: CCCCACCAGTCAGGACTAAA
GRK4-Cod4 F: AGGGAGCCAACAGAACACTG
R: TGGAAAGGACAAGACACTGAG
Hprt F: GTAATGATCAGTCAACGGGGAC
R: CCAGCAAGCTTGCAACCTTAACCA
TBP F: AGGCCAGACCCCACAACTC
R: GGGTGGTGCCTGGCAA
Chemical and enzymatic probing of Cod2a- region
Cod2a-RNA (3 pmoles) was denatured at 90◦C for 1 min,
then immediately incubated on ice for 1 min and equili-
brated in the appropriate native buffer (50mMHepes buffer
pH 7.5 for dimethyl sulfide (DMS) or borate buffer pH
8 for N-Cyclohexyl-N′-(2-morpholinoethyl-carbodiimide
(CMCT) , 5 mM Mg acetate, 50 mM KOH acetate, 2 mM
-mercaptoethanol) for 15 min at room temperature (RT).
Chemical modifications were performed in 20 l final vol-
ume using either 1 l of DMS (undiluted or diluted 1/2
in ethanol) or 60 or 20 g of CMCT, at 20◦C for 5 and
10 min, respectively and in the presence of 2 g of yeast
total tRNA (Ambion). Enzymatic modifications were per-
formed with V1 (0.1 U and 0.01 U), T1 (0.05 U and 0.1 U)
and A (1 g/ml and 0.1 g/ml) nucleases (Promega) for 5
min at RT, followed by ethanol precipitation. After solubi-
lization in the appropriate buffer, modified RNAs were re-
verse transcribed using the  -32ATP 5′-end labeled GRK4-
Cod2a- R primer, sequencing reactions and gel analysis
were carried out as previously described (18).
Fluorescent primer extension of GRK4 mRNA
A modified GRK4 mRNA harboring a sequence com-
plementary to M13 Rev primer was generated by PCR
using T7-grk-4 1110 F (gactgactTAATACGACTCAC-
TATAGGGgactCCAAAGATGCCTTGTGCTTG) and
m13 rev grk4 1253 R (CACACAGGAAACAGCTAT-
GACGTATACAATTCTTTCCCTCTG) primers. PCR
product was purified (Qiagen Minelute Spin Column)
and used as template in an in vitro transcription reaction
incubated for 3 h at 37◦C. The RNA product was purified
by PAGE and its concentration was adjusted to 0.1 g/l.
5′-VIC R©, 6-fluorescein amidite (6-FAM), NEDR© and
PET R© labeled M13rev primers (Life Technologies) were
used at 1.25 M. RNA structure was interrogated using
various chemicals and enzymes, DMS, CMCT, RNAseT1,
RNAseA and RNAseV1 as described above. The fluores-
cently labeled DNA primer were added to the modified
Figure 1. GRK4 expression in Fmr1 null mouse cerebellum. (A) Quan-
titative RT-PCR reveals no difference between the Grk4 mRNA level in
cerebella obtained from 3 months aged wild-type mice (N=6) and from 3
months aged Fmr1-null mice (N=6). (B) Representative western-blot anal-
ysis of one cerebellum of wild-typemouse and one cerebellum of Fmr1-null
mouse. Size ofGrk4 (60 kD) and-actin (42 kD) are indicated on the left of
the western blot. (C) Densitometric analysis showing a significant increase
of Grk4 expression: six cerebella of wild-type cerebella and six cerebella
Fmr1 knock-out mice are compared. Results are the average of Grk4 lev-
els normalized by -actin expression. Results are presented as the mean
+/− SEM (Mann–Whitney test, P < 0.05).
T7–2a2 m13rev RNA (100 g). VIC was used for the (+)
and (−) reagent channels and NED or PET was used
for the sequencing reaction channels. The RNA-primer
solution was diluted to 6 l with water and incubated
at 95◦C for 1 min, 4◦C for 1 min and 20◦C for 15 min
in RT buffer (Tris–HCl 50 mM (pH 8,5), MgCl2 6 mM,
KCl 40 mM). Primer extension was initiated by addition
of enzyme mix [9 l; Tris–HCl 50 mM (pH 8,5), MgCl2
6 mM, KCl 40 mM] and 2.5 mM dNTP and 20 units
SuperScript II (Invitrogen). Reactions were performed
at 37◦C for 30 min. Sequencing reactions were identical,
except that they used unmodified RNA (100 ng) and a
modified dNTP set containing 1 mM of each dNTP, except
the one corresponding to the dideoxy sequencing that was
adjusted to 0.25 mM and 33 M of this ddNTP. Exten-
sions were quenched by precipitation with 100% ethanol,
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Figure 2. FMRP binds specifically GRK4 mRNA in vitro and in vivo. (A)
Schematic representation of human GRK4 mRNA (BC117320) and the
fragments subcloned from full-length cDNA and used to map the bind-
ing domain of FMRP on GRK4mRNA. (B) Binding specificity of FMRP
to GRK4mRNA. Filter binding assay was performed by using full-length
FMRP and 32P-labeled N19 probe. The competition was performed us-
ing various regions of unlabeled GRK4 mRNA: 5′ UTR region, Cod1,
Cod2 fragments, N19 itself and 35 (the N19 fragment carrying the dele-
tion of the G-quadruplex structure, as shown in Supplementary Figure
S2A). The graph depicts the fraction of bound labeled N19 RNA plot-
ted against unlabeled competitor RNA concentration. (C) The same ex-
perimental procedure described in (B) but the competition was performed
using different regions of unlabeled GRK4, namely Cod3 and Cod4, and
the two controls N19 and  35. (D) CLIP analysis experiment. RNA
co-immunoprecipitated with FMRP after UV-crosslink, was analyzed by
qRT-PCR using specific oligos localized in the GRK4 subdomains we de-
termined for the in vitro analysis. Hprt was used as a negative control. Re-
sults are presented as the mean +/− SEM (N = 4).
Figure 3. Domains of FMRP interacting with the mRNA of GRK4. (A)
Architectural organization of FMRP domains. (B) Filter binding assay,
using various recombinant RNA-binding domains of FMRP: KH1, KH2
and the C-terminal domain containing the RGG box and 32P-labeled
RNAs, reveals that the FMRP C-terminal domain (FCT) displays equal
affinity for Cod2 fragment or G-quadruplex (N19 RNA), whereas the two
KH domains are not able to bind Cod2 mRNA as well as N19 RNA.
washed with 70% ethanol and redissolved in 10 l of highly
deionized formamide supplemented with LIZ labeled
DNA ladder (Life technologies), except the sequencing
reactions that were resuspended in 5 l of highly deionized
formamide supplemented with LIZ labeled DNA ladder
(Life technologies). Two sequencing reactions for each
extension using the same primer sequence but labeled with
a different fluorophore were mixed with one (+) or (−)
reaction. Each resulting mix was loaded in a capillary on
an Applied Biosystems 3130XL capillary electrophoresis
DNA sequencer. Electropherograms were generated and
analyzed with the QuShape software (21,22).
Luciferase assays
STEKcells, expressing or not FMRP (23) were seeded in 96-
well plates (20 000 cells/well) and were immediately trans-
fected with psiCHECK-2-derived constructs using Lipofec-
tamine 2000 (Invitrogen) following the manufacturer’s in-
structionswith slightmodification as follows: 60 ng ofDNA
were used per well with 0.5 l of Lipofectamine 2000. After
48 h, medium was removed and cells were lysed in 70 l of
1× passive lysis buffer (Promega); renilla and firefly activi-
ties were measured with the Dual-Glo luciferase assay sys-
tem (Promega) using a Glomax 96-well plate luminometer
(Promega). mRNA levels of Renilla and Firefly Luciferase
were analyzed by RT-qPCR using the following primers:
 RLucF: TCCATGCTGAGAGTGTCGTG;
 RLucR: ATTTTCTCGCCCTCTTCGCT;
 FLucF: GACACCGCTATTCTGAGCGT;
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Figure 4. Sequences of the GRK4 mRNA interacting with FMRP. (A)
Scheme of the different subclones we generated from Cod2. Their size
and their position in the coding sequence of GRK4 are indicated. (B)
Filter binding assay using FMRP and 32P-labeled N19. The competition
was performed using various regions of unlabeled GRK4 mRNA: Cod2a
and Cod2b fragments. The two control N19 and 35 were also used as
competitors. (C) Filter binding assay using FMRP and 32P-labeled N19.
The competition was performed using various regions of unlabeled GRK4
mRNA: Cod2a- and Cod2a- fragments. The two control N19 and 35
were also used as competitors. Each experiment was repeated four times.
 FLucR: GTACATCAGCACCACCCGAA
Statistical analyses
All statistical analyses and graphs were realized using the
GraphPad Prism Version 6.0e. http://www.graphpad.com/
support/faq/whats-new-in-prism-mac-60e/.
RESULTS
Grk4 expression is impaired in the cerebellum of Fmr1-null
mice
Grk4mRNA has been found to be a component of FMRP-
containing mRNP-complexes in cultured primary neurons
by using the APRA (Antibody-positioned RNA amplifi-
cation) technique (24). In order to assess whether FMRP
modulates GRK4 expression, we studied Grk4 levels in the
presence or in the absence of FMRP in various brain re-
gions. We tested the expression of Grk4 mRNA in mouse
cerebellum, hippocampus and cortex in wild-type versus
Fmr1 null adult animals. No differences have been observed
in Grk4 mRNA level by RT-qPCR in any analysis we per-
formed in two different genetic backgrounds (C57BL/6 and
Figure 5. Sequence and structure of RNA domains interacting with
FMRP. (A) Mouse and human sequence of G4RIF. The ACUK/WGGA
motifs are highlighted in blue. (B) Six percent PAGE gel showing the run-
ning of retro transcribed G4RIF cDNA after treatment with DMS (mod-
ifying unpaired A and C) or CMCT (modifying unpaired G and U) (see
also (6)). (C) RNA secondary structure model of G4RIF showing results
from enzymatic cleavage and chemical modification experiments. The sym-
bols indicating the reactivity are displayed and ACUK/WGGA sequences
are shown in blue characters like in (A).
FBV) (Figure 1A). Conversely, the expression of GRK4
protein by western blot in the cerebellum of wild-type and
Fmr1 adult knockout mice showed a higher level (30%) in
both genetic backgrounds in the absence of FMRP (Fig-
ure 1 B and C), while no differences were observed in hip-
pocampus and cortex of mice (not shown) at the same age.
These results suggested that FMRP modulates the expres-
sion ofGRK4 at the translational level acting as a repressor,
as it has also been shown for many other mRNA targets of
this protein (4).
FMRP binds the mRNA of GRK4 in vitro and in vivo
To show thatGRK4mRNA is a target of FMRP,we decided
to test FMRP/GRK4mRNA interaction in vitro and in vivo.
To this purpose, we subcloned the cDNA of human GRK4
into five fragments (Figure 2A) and we used these cDNAs
to produce the corresponding RNAs and to test their in-
teraction with FMRP by a filter binding assay in the pres-
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Figure 6. Influence of FMRP on luciferase reporter gene assay bearing G4RIF. psiCHECK-2 plasmid expressing Renilla bearing S1/S2 or S3/S4 or
DegS1/S2 or DegS3/S4G4RIF subregions were transfected in STEK cells. Three independent experiments with three replicates for each transfection, were
quantified. For each transfection Renilla luciferase activity (R) was normalized with Firefly luciferase activity (L). In order to facilitate the comparison
between native and degenerated sequences in WT and KO cells, ratios for all conditions were divided by the mean of the signal obtained for the cognate
native sequences in the WT cells. Results are presented as the mean ±SEM (two way ANOVA, *P < 0.05). (A) S1/S2 or S3/S4 or DegS1/S2 or DegS3/S4
sequences have been cloned in the 5′ UTR of the Renilla reporter; (B) S1/S2 or S3/S4 or DegS1/S2 or DegS3/S4 sequences are cloned in frame with the
coding sequence of the reporter gene; (C) S1/S2 or S3/S4 or DegS1/S2 or DegS3/S4 sequences are cloned in the 3′ UTR of the reporter gene.
ence of competitor RNA, the N19 probe contaning a G-
quadruplex-forming structure, a motif that is well-known
to interact with the RGG-box domain of FMRP (18,25).
Only the Cod2 fragment competes with N19 mRNA bind-
ing to FMRP with the same affinity as N19 mRNA itself
(Figure 2B). The Cod1mRNA competed with N19 binding
to FMRP with very low affinity (Figure 2B) (one order of
magnitude lower than Cod2) and, on the basis of our previ-
ous experience (18), we did not further study a target having
such aweak affinity for FMRP. The other four fragments do
not interact with FMRP since they did not compete with
N19 binding to FMRP (Figure 2C), similarly to the nega-
tive control 35 (the N19 probe carrying a deletion of 35
nt that are key in the G-quadruplex folding structure) (26).
To confirm FMRP/GRK4 mRNA interaction in vivo, we
used CrossLinking ImmunoPrecipitation (CLIP) analysis.
After UV irradiation, cerebellum slices obtained from wild-
type and Fmr1 null mice were lysed and the extracts were
subjected to mild RNAse digestion. Immunoprecipitation
of FMRP mRNA complexes was carried out on these ex-
tracts using the polyclonal anti-FMRP antibody #R60 (20)
(Supplementary Figure S1). RT-qPCR analysis of mRNAs
extracted from both input RNAs and immunoprecipitates
was then carried out using primers located in the five sub-
regions of the mRNA of GRK4 previously defined and us-
ingHprt as a negative control. This analysis revealed an en-
riched association of FMRP with the Cod2 region and a
modest association with the Cod1 region (Figure 2D), con-
firming the in vitro results we obtained (Figure 2B).
RGG-box domain is involved in GRK4 mRNA/FMRP inter-
action
To assess which domain of FMRP was able to interact with
GRK4 mRNA, we produced the protein fragments of the
different RNA-binding domains of FMRP (KH1, KH2,
KH1/2 and RGG box-containing-C-terminal domains) as
recombinant proteins in a bacterial system (6) and we used
them in binding assays with the GRK4-Cod2 RNA. The
structural organization of FMRP is shown in Figure 3A.
Interestingly, we observed that GRK4-Cod2 RNA interacts
only with the C-terminal domain of FMRP (RGG) (Fig-
ure 3B), similarly to the positive control, the N19 RNA.
Conversely,GRK4-Cod2RNAwas not able to interact with
any of the KH domains even at high protein concentration
(Figure 3B). The RGG box domain is known to bind not
only to the G-quadruplex RNA structure (25) but also to
the So-SLIP motif (6).
Definition of the critical region of GRK4 RNA bound by
FMRP
In order to define the molecular determinant of the
FMRP/GRK4mRNA interaction, we decided to finely de-
fine the RNA fragment of GRK4 that is bound by FMRP.
For this purpose, we generated the sub-clones Cod2a and
Cod2b from the Cod2 fragment (Figure 4A) and we per-
formed a binding assay that allowed us to show that only
the RNA obtained from the Cod2a fragment interacts with
FMRP by competing the FMRP/N19 interaction with the
same affinity as Cod2 (Figure 4B). We also generated two
sub-clones from Cod2a, namely Cod2a- and Cod2a-
(Figure 4A). Binding assay revealed that only the RNA ob-
tained from the Cod2a- mRNA interacts with FMRP by
competing the FMRP/N19 interaction with the same affin-
ity as Cod2/Cod2a (Figure 4C), while the Cod2-RNAdid
not compete with the N19 probe. Since the GRK4-Cod2a-β
RNA sequence harbors several ACUK/WGGA (27) mo-
tifs that are targeted by FMRP and that can fold in a G-
quadruplex forming structure (11), we investigated the pres-
ence of a G-quadruplex in the GRK4 mRNA critical re-
gion for FMRP interaction.We took advantage of the prop-
erty of G-quadruplex forming regions to exhibit strong re-
verse transcription pauses when performed in K+ contain-
ing buffer (18,23). Indeed, stabilization of G-quadruplex
structures by K+, but not by Li+ or Na+, results in cation-
dependent pauses detectable on a sequencing gel that are
readily observable when using for the positive control se-
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Figure 7. FMRP protection of SL1. (A) Relative CMCT reactivities along
the G4RIF sequence. We used the QuShape software to quantify the re-
activities of each nucleotide toward the CMCT probe in the presence of
BSA or FMRP. BSA reactivities were subtracted to those in the presence
of FMRP, providing a relative reactivity of each nucleotide to the CMCT
probe in the presence of FMRP along the whole G4RIF sequence (Sup-
plementary Table SI). We then summed the relative reactivities for 20 con-
secutive nucleosides to identify the sequence that is protected by FMRP.
The relative reactivities of these 20-mer bins were plotted as a function of
the G4RIF sequence. A sharp increase in the computed relative reactiv-
ities, highlighting the protection by FMRP, corresponds to the SL1 part
of G4RIF sequence that is represented with blue dots on the graph. An
exemple of a 20mer bin, centered on a  A  whose relative reactivity is
shown as a red plot on the graph, is represented by the red rectangle at the
bottom of the figure. (B) CMCT reactivities along the SL1 and SL2 part
of the G4RIF in the presence of BSA (red line) or FMRP (blue line) are
displayed with the corresponding sequence at the bottom of the figure. In
the presence of FMRP (1 M), a 20 nt sequence at the 3’ end of SL1 is less
reactive toward the CMCTprobe than in the presence of BSA (1M). Col-
ored dots above the sequence represent the relative protection by FMRP.
Dark blue dots represent a stronger protection than light blue dots. Red
dots represent a higher sensitivity to the CMCT probe in the presence of
FMRP. ACUK/WGGA sequences are displayed in blue and underlined.
(C) RNA secondary structure model of SL1/SL2 sequence showing results
from chemical modification experiments in the presence of FMRP. Dark
blue dots represent a stronger protection than light blue dots. Red dots
represent a higher sensitivity to CMCT probe in the presence of FMRP.
quence N19 (Supplementary Figure S2A). The experiments
were performed both on the Cod2a and GRK4 mRNAs (as
explained in ‘Materials and Methods’ section and in the
legend of the Supplementary Figure S2) in order to com-
pletely cover the Cod2 RNA fragment. This analysis al-
lowed us to show that the fragments do not exhibit any
pause in the presence of K+, ruling out the presence of a G-
quadruplex structure in the Cod2 mRNA (Supplementary
Figure S2B) as well as in the negative control 35 (Supple-
mentaryFigure S2A). These datawere confirmed by in silico
prediction using the QGRS web tool http://bioinformatics.
ramapo.edu/QGRS/index.php (not shown).
Structure of G4RIF, the minimal region of the GRK4mRNA
interacting with FMRP
The human and mouse sequences of Cod2a- RNA are
shown in Figure 5A. They display 81% identity and con-
tain five ACUK/WGGA motifs, that are highlighted in
blue in the figure. To unravel the molecular bases of
GRK4/FMRP interaction we decided to determine the
structure of the GRK4 Critical RNA Region Interacting
with FMRP (G4RIF). To this purpose, we probed the struc-
ture of this region in solution, using a panel of chemical
and enzymatic modifications (Figure 5B), as previously de-
scribed (6). Our analysis showed a complex structure orga-
nized in two pairs of stem-loops that we named SL1, SL2,
SL3 and SL4. SL1 loop harbors a ACUK/WGGA mo-
tif (UUGA), while other ACUK/WGGA motifs are local-
ized in regions of double-stranded RNA (stem) (Figure 5C)
(Supplementary Figures S3 and S4).
Role of the FMRP/G4RIF complex in translation
To investigate the functional role of the G4RIF/FMRP
complex in translation we sub-fractioned Cod2a- in two
fragments S1/S2 encompassing SL1 and SL2 stem loops
and S3/S4 encompassing SL3 and SL4 stem loops. The
corresponding sequences were inserted in the 5′ UTR, in
the 3′ UTR or in the coding sequence of the Renilla lu-
ciferase in the psiCHECK-2 vector. To control for the
specificity of binding to FMRP, we subcloned also the
degenerated S1/S2 and S3/S4 sequences (DegS1/S2 and
DegS3/S4 constructs, respectively) at the same position
as the native sequences in the 5′ UTR, in the 3′ UTR
or in the coding sequence of the Renilla luciferase in the
psiCHECK-2 vector. These mutated sequences give rise to
the same protein sequences but fold into different RNA
structures than the native S1/S2 and S3/S4 sequences, ac-
cording to the mfold program (http://helix.nih.gov/apps/
bioinfo/mfold.html). We transfected STEK fibroblasts ex-
pressing or not the FMR1 gene (23) with the different con-
structions or with the psiCHECK-2 vector and we mea-
sured Firefly (F) and Renilla (R) luciferase activities. The
ratio of the R on F activities showed on average two-fold
increase (P < 0.05 two way ANOVA) when S1/S2 mRNA
is in framewith theR luciferase coding sequence the (Figure
6B), but not for any of the other conditions (Figure 6A and
C), suggesting the relevance of the S1/S2 domain in trans-
lational regulation via the G4RIF/FMRP interaction. We
could also verify by RT-qPCR that the relative level of ex-
pression of the R luciferase mRNA of each construct were
identical in the presence and in the absence of FMRP (not
shown) when normalized by the F luciferase mRNA. Col-
lectively, these findings confirm the data we obtained on en-
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dogenous expression levels of Grk4 (mRNA and protein)
shown in Figure 1.
To gain further insight into the mechanistic action of
FMRP in translational regulation of GRK4, we also per-
formed mapping experiments in the presence of FMRP.
To precisely quantify the impact of FMRP on the G4RIF
structure we used fluorescent primer extensions followed by
capillary electrophoresis. We investigated the interaction of
FMRP with the G4RIF using CMCT (that reacts with un-
paired U andG nucleosides) andDMS (that reacts with un-
pairedA andC nucleosides) probes.We couldmap precisely
FMRP interaction with the SL1/SL2 region of the G4RIF
that is more reactive toward CMCT than DMS. Capillary
electrophoresis signals obtained in the presence of bovine
serum albumin (BSA) or FMRP were analyzed with the
QuShape software (21,22). We calculated the relative reac-
tivities of each nucleoside of the G4RIF in the presence of
FMRP and in the presence of BSA (Supplementary Table
SI). Since it was reported that the median protein footprint
size is 40 nucleoside-long (28), roughly corresponding to the
size of the S1/S2 fragment, we reasoned that to identify
a consecutive stretch of protected nucleosides by FMRP,
we could use a sliding window strategy using binned 20-
mer in order to isolate the SL1 from the SL2 protections
adapted from (29). To this purpose, for each nucleoside of
the G4RIF, we summed the relative reactivities of the 10
preceding nucleosides and the 10 following nucleosides and
plotted the result as a function of theG4RIF sequence (Fig-
ure 7A) and an example of our procedure is shown in Sup-
plementary Table SI. This analysis highlighted clearly that
the SL1 region is protected by FMRP (Figure 7A) from
the CMCT probe. A close view at the electropherograms in
the presence of FMRP or BSA (Figure 7B) confirmed that
FMRP exerts a greater protection on the SL2 RNA from
the CMCT probe than the BSA. We reported these protec-
tions on the G4RIF sequence (Figure 7C).
DISCUSSION
We describe here a newmRNA target of FMRP, the protein
that is absent in FXS. This mRNA encodes GRK4, a mem-
ber of the guanine nucleotide-binding protein (G protein)-
coupled receptor kinase superfamily of the Ser/Thr protein
kinase family. Our findings provide novel information con-
cerning the role of FMRP in cerebellum and we propose
that the absence of FMRP/GRK4 mRNA interaction can
have a role in the pathophysiology of FXS.
FMRP interacts with a new RNA motif: G4RIF
We identified the fragment (G4RIF) of the coding re-
gion of the GRK4 mRNA that is bound specifically and
with high affinity by FMRP and we defined its structure
in vitro. Interestingly, this fragment is organized in four
stem loops (namely SL1, SL2, SL3 and SL4) and con-
tains five ACUK/WGGA sequences that have been de-
scribed as short motifs mediating RNA/FMRP interac-
tion (27). We noticed that many other ACUK/WGGA
sequences are present in other mRNA regions of GRK4
mRNA that do not interact with FMRP, leading to the con-
clusion that ACUK/WGGA motifs are not sufficient per
se to mediate GRK4 mRNA/FMRP interaction. In addi-
tion, we excluded that the WGGA motifs generate a G-
quadruplex structure in the critical G4RIF mRNA, as pre-
dicted in silico for other mRNA targets of FMRP (11).
Taken together, these results strongly suggest the existence
of a new structure/motif mediating GRK4 mRNA/FMRP
interaction. Interestingly, a UUGA (ACUK/WGGA mo-
tif) sequence is present in the SL1 loop (Figure 5B), highly
protected by FMRP (Figure 7C), and that is a part of
the S1/S2 sequence that increases the translation of a re-
porter mRNA when inserted in frame with it. Since the
G4RIF motif is part of the coding region of the GRK4
mRNA, we suggest that the position of the UUGA in
the stem loop is important in the context of the target
mRNA in order to allow FMRP to carry out its func-
tion. As for GRK4 mRNA, another study observed that
most mRNAs are associated with FMRP on brain trans-
lating polyribosomes via their coding sequence (8), prob-
ably because FMRP also interacts with the ribosomal L5
protein blocking/stalling translation (30). Moreover, we
also noticed that a ACUK/WGGA motif (AUGA) is lo-
cated in loop 2 of the SoSLIP structure, a motif that we
have shown to mediate FMRP/Sod1 mRNA interaction
(4,6). Collectively, these results suggest that the presence
of ACUK/WGGA motifs can be relevant for FMRP func-
tion when located in a specific structural context. As in the
two mentioned cases, we can speculate that the stem loop
provides a structure that allows the UUGA or AUGA se-
quences to be accessible to FMRP binding. SoSLIP trig-
gers translation activationwhileG4RIF is involved in trans-
lational repression, however SoSLIP is located at the end
of the 5′ UTR/beginning of the coding sequence (being an
IRES) (6), while G4RIF is located in the coding region of
theGRK4mRNA (this study). Moreover, additional motifs
or proteins can cooperate with FMRP to carry out its dif-
ferent roles in translation. Till date, studies of FMRP/RNA
interaction generated two sets of results: (i) FMRP interacts
with RNA structures such as G-quadruplex, SoSLIP, Kiss-
ing loop (4); (ii) FMRP recognizes short sequences such
as ACUK/WGGA motif and polyU (4). Our findings sug-
gest that both sequence and structure are important for
FMRP interactionwithRNA for some targets and they rep-
resent a valuable advance in the dissection of the molecular
function of FMRP. To our best knowledge, this is the first
study showing that FMRP specifically binds a motif result-
ing from a structure/sequence combination. Conversely, a
sequence/structure combination is known to be bound by
Smaug (31) and, in this case, the position of the targeted
motif into the bound RNA does not appear to be relevant
for its functional significance (32).
We observed that the RGG box domain mediates the in-
teraction between FMRP and the GRK4 mRNA. It is in-
teresting to underline that another study reported that the
FMRPKH2 domain interacts with the ACUK/WGGA se-
quences. This data was established considering that FMRP
carrying the pathological, I304N mutation––causing a se-
rious form of FXS––does not bind them (27). However,
while we have shown a direct interaction between Cod2
RNA and the C-terminal domain of FMRP and no inter-
action with the KH1 and the KH2 domains, no isolated
KH2 domain was tested in binding with ACUK/WGGA
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sequences by the previous study (287). Thus, it might be
possible that the I304N full length protein is not properly
folded, resulting in a general loss of affinity for RNA and
not only for ACUK/WGGA. Indeed, for instance, I304N
was shown to be unable to interact with homopolymer poly
(G)RNA (33), that is a non-specific target of FMRP In con-
clusion, the C-ter domain of FMRP binds ACUK/WGGA
in a specific structural context (as for G4RIF and SoSLIP)
or when these motifs are organized in G-quadruplex struc-
tures (4,11,18). We cannot exclude that KH2 may recog-
nize and bind ACUK/WGGA sequences in a not yet iden-
tified structural motif other than G4RIF/SoSLIP or G-
quadruplex. Remarkably, the GRK4 mRNA represents an
additional target RNA of FMRP bound by the C-terminal
region of FMRP and likely by the RGG box domain. This
aspect is very interesting and renovates the question of how
this domain can bind and discriminate different RNA struc-
tures (e.g. G-quadruplex, SoSLIP,G4RIF) (4).Methylation
is a modification that is important for FMRPRGG activity
(34) and that could play a role in its capacity to bindmRNA
(35). All our data were obtained using FMRP produced in
bacteria, where such post-translational modification is not
made. In addition, we confirmed our findings using recom-
binant FMRP produced in baculovirus and/or by in vivo
CLIP analysis (6,18,23 and this study), thus excluding a role
of a modified RGG box in its specificity of RNA binding.
Cerebellar dysfunction in FXS: possible pathophysiological
role of altered expression of GRK4
An important aspect of our study is that we found an
increased expression of GRK4 only in the cerebellum of
Fmr1-KO mice compared with controls. This suggests that
FMRP has an important role in this tissue to regulate the
translation of this particular mRNA. GRK4 is a regulatory
protein required to promote GBR desensitization. GBRs
are metabotropic G-protein coupled receptors regulating
multiple downstream signaling cascades (36). In particular,
in cerebellum GBRs signaling has a relevant role in motor
coordination and motor learning (13). It was reported that
GRK4-dependent desensitization of GBR occurs in the ab-
sence of an increased receptor phosphorylation in cerebel-
lum and does not require the catalytic activity of the kinase,
suggesting that GRK4 possesses a function other than its
kinase activity (12). Thus, in the absence of FMRP, an ele-
vated level of GRK4 in cerebellum might promote a higher
rate of constitutive desensitization of GBR specifically in
this brain region contributing to deficits of motor learning
andmovement coordination that are cerebellum-dependent
phenotypes of FXS patients (14). It is known that GBRs
have a role also in the pathophysiology of FXS. Indeed an
activation of GBRs by arbaclofen (a well known agonist of
GBR) has been shown to correct some major phenotypes
of the FXS mouse model (37) and improved behavior of a
subgroup of FXS patients (38) but the effect of arbaclofen
onmotor learning/coordinationwas nevermonitored in de-
tail. We propose here that molecules that can modulate the
action of GRK4 might be useful to try specific therapies
targeting cerebellum-dependent phenotype of FXS patients
improving their quality of life.
A big effort has been performed during the last 15 years
resulting in hundreds of mRNAs identified as targets of
FMRP, however only a few motifs mediating these interac-
tions have been precisely characterized. For these reasons,
we are convinced that the full understanding of molecu-
lar bases of FMRP/RNA interaction is still far to be com-
pleted.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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